IDELVION

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom

Active ingredients

The drug IDELVION contains one active pharmaceutical ingredient (API):

1 Coagulation factor IX
UNII A57KX1VL5P - ALBUTREPENONACOG ALFA

Factor IX is a single chain glycoprotein with a molecular mass of about 68,000 Dalton. It is a vitamin-K dependent coagulation factor and it is synthesised in the liver. Factor IX is activated by factor XIa in the intrinsic coagulation pathway and by the factor VII/tissue factor complex in the extrinsic pathway. Activated factor IX, in combination with activated factor VIII, activates factor X.

Read about Coagulation factor IX

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B02BD04 Coagulation factor IX B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 502619030008507, 502619030008607, 502619030008707, 502619030008807
Country: CA Health Products and Food Branch Identifier(s): 02451352
Country: EE Ravimiamet Identifier(s): 1718625, 1718636, 1718647, 1718658, 1826119
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1161095001, 1161095002, 1161095003, 1161095004
Country: FR Base de données publique des médicaments Identifier(s): 60216127, 63102506, 65247870
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 328156, 328160, 328188, 328194
Country: HK Department of Health Drug Office Identifier(s): 65142, 65143, 65144, 65145
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8411, 8412, 8413
Country: JP 医薬品医療機器総合機構 Identifier(s): 6343448D1020, 6343448D2026, 6343448D3022, 6343448D4029, 6343448D5025
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1080374, 1080375, 1080376, 1080377, 1091048
Country: NL Z-Index G-Standaard Identifier(s): 14281910, 14281929, 14281937
Country: NL Z-Index G-Standaard, PRK Identifier(s): 132365, 132373, 132403, 132500
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 18603, 18604, 18605, 18606, 22393
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100372514, 100372520, 100372773, 100372796, 100461213
Country: SG Health Sciences Authority Identifier(s): 15811P, 15812P, 15813P, 15814P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681624980330, 8681624980347, 8681624980354, 8681624980361

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.